Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach

SIMPLE SUMMARY: Cholangiocarcinoma (CCA) is a group of rare cancers that are associated with poor prognosis. Biomarker testing may provide CCA patients access to effective, personalized treatment options. However, several barriers exist to the seamless adoption of precision medicine in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, May T., Gholami, Sepideh, Gui, Dorina, Tejaswi, Sooraj L., Fananapazir, Ghaneh, Abi-Jaoudeh, Nadine, Jutric, Zeljka, Samarasena, Jason B., Li, Xiaodong, Valerin, Jennifer B., Mercer, Jacob, Dayyani, Farshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773504/
https://www.ncbi.nlm.nih.gov/pubmed/35053557
http://dx.doi.org/10.3390/cancers14020392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773504/
https://www.ncbi.nlm.nih.gov/pubmed/35053557
http://dx.doi.org/10.3390/cancers14020392

Ejemplares similares